Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly (Spermine Acrylamides) for the Treatment of Lung Fibrosis

F Adams, CM Zimmermann, D Baldassi, TM Pehl… - Small, 2023 - Wiley Online Library
RNA interference (RNAi) is an efficient strategy to post‐transcriptionally silence gene
expression. While all siRNA drugs on the market target the liver, the lung offers a variety of …

Molecular Dynamics Simulations Elucidate the Molecular Organization of Poly (beta-amino ester) Based Polyplexes for siRNA Delivery

KM Steinegger, L Allmendinger, S Sturm… - Nano Letters, 2024 - ACS Publications
Cationic polymers are known to efficiently deliver nucleic acids to target cells by
encapsulating the cargo into nanoparticles. However, the molecular organization of these …

Design of Experiments Grants Mechanistic Insights into the Synthesis of Spermine-Containing PBAE Copolymers

APE Kromer, F Sieber-Schäfer… - … Applied Materials & …, 2024 - ACS Publications
Successful therapeutic delivery of siRNA with polymeric nanoparticles seems to be a
promising but not vastly understood and complicated goal to achieve. Despite years of …

Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy

S Soghrati, J Varshosaz, M Rostami… - Journal of Materials …, 2025 - pubs.rsc.org
Combinational therapy to treat triple-negative breast cancer (TNBC) by concomitantly
influencing different cellular pathways has attracted attention recently. In the present study …

Role of Hydrophobic Modification in Spermine-Based Poly (β-amino ester) s for siRNA Delivery and Their Spray-Dried Powders for Inhalation and Improved Storage

Y Jin, X Wang, APE Kromer, JT Müller… - …, 2024 - ACS Publications
After RNAi was first discovered over 20 years ago, siRNA-based therapeutics are finally
becoming reality. However, the delivery of siRNA has remained a challenge. In our previous …

A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer

S Chen, M Triki, SP Carneiro, OM Merkel - Nanoscale, 2025 - pubs.rsc.org
CRISPR-Cas9 has emerged as a highly effective and customizable genome editing tool,
holding significant promise for the treatment of KRAS mutations in lung cancer. In this study …

[PDF][PDF] Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer

S Chen - 2024 - edoc.ub.uni-muenchen.de
1. Abstract According to the Global Cancer Statistics 2022, lung cancer is the most
commonly diagnosed cancer and the leading cause of cancer-related deaths worldwide. 1 …